Evidence map›Paper›PMID 39826846›Full record

ArticleInternational journal of radiation oncology, biology, physics2025

International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study.

Amy C Moreno, Erin E Watson, Laia Humbert-Vidan, Douglas E Peterson, Lisanne V van Dijk, Teresa Guerrero Urbano, Lisa Van den Bosch, Andrew J Hope, Matthew S Katz, Frank J P Hoebers and 59 more

Abstract readConsensus Statement
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Post-COVID-19 Jaw Osteonecrosis: A Narrative Review.Medicina (Kaunas, Lithuania) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Radiographic classification of mandibular osteoradionecrosis: A blinded prospective multi-disciplinary interobserver diagnostic performance study.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

69 authors.

Amy C MorenoDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: akmoreno@mdanderson.org.
Erin E WatsonDepartment of Dental Oncology/Faculty of Dentistry, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Laia Humbert-VidanDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Douglas E PetersonDepartment of Oral Health and Diagnostic Sciences, University of Connecticut, Farmington, Connecticut.
Lisanne V van DijkDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Teresa Guerrero UrbanoOncology Department, Guy's and St Thomas NHS Trust/King's College London, London, United Kingdom.
Lisa Van den BoschDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Andrew J HopeDepartment of Radiation Oncology, Princess Margaret Cancer Centre; University Health Network, University of Toronto, Toronto, Ontario, Canada.
Matthew S KatzDepartment of Radiation Oncology, Lowell General Hospital, Lowell, Massachusetts.
Frank J P HoebersDepartment of Radiation Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
Ruth A Aponte WessonDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
James E BatesDepartment of Radiation Oncology, Winship Cancer Institute/Emory University, Atlanta, Georgia.
Paolo BossiMedical Oncology, Department of Medical and Surgical Specialties, Humanitas University, IRCCS Humanitas Research Hospital, Milan, Italy.
Adeyinka F DayoOral Medicine Department, University of Pennsylvania School of Dental Medicine, Philadelphia, Pennsylvania.
Mélanie DoréRadiotherapy Department, Institut de Cancérologie de l'Ouest, Saint Herblain, France.
Eduardo Rodrigues FregnaniCentro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil.
Thomas J GallowayDepartment of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Daphna Y GelblumDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Issa A HannaKatz Department of Oral and Maxillofacial Surgery, UTHealth Houston School of Dentistry, Houston, Texas.
Christina E HensonDepartment of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Sudarat Kiat-AmnuayDepartment of General Practice and Dental Public Health, UTHealth Houston School of Dentistry, Houston, Texas; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Anke KorfageDepartment of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Nancy Y LeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Carol M LewisDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Charlotte Duch LynggaardDepartment of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Antti A MäkitieDepartment of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Marco MagalhaesFaculty of Dentistry, Oral Pathology and Oral Medicine, University of Toronto, Toronto, Ontario, Canada.
Yvonne M MoweryDepartment of Radiation Oncology, UPMC Hillman Cancer Center/University of Pittsburgh, Pittsburgh, Pennsylvania.
Carles Muñoz-MontpletMedical Physics and Radiation Protection Department, Catalan Institute of Oncology-Girona, Girona, Spain.
Jeffrey N MyersDepartment of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ester OrlandiDepartment of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia/Clinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Jaymit PatelDepartment of Restorative Dentistry, Leeds Teaching Hospitals Trust, Leeds, United Kingdom.
Jillian M RigertDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Deborah SaundersDepartment Dental Oncology, Health Sciences North, Northern Ontario School of Medicine University, Sudbury, Ontario, Canada.
Jonathan D SchoenfeldDepartment of Radiation Oncology, Dana Farber-Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
Ugur SelekDepartment of Radiation Oncology, School of Medicine, Koc University, Istanbul, Turkey.
Efsun SomayDepartment of Oral and Maxillofacial Surgery, Baskent University, Ankara, Turkey.
Vinita TakiarDepartment of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Juliette ThariatDepartment of Radiation Oncology, Comprehensive Cancer Centre François Baclesse, Caen, France.
Gerda M VerduijnDepartment of Radiation Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
Alessandro VillaOral Medicine, Oral Oncology, Miami Cancer Institute, Baptist Heath South Florida, Miami, Florida.
Nicholas S WestNorthern Centre for Cancer Care, Newcastle upon Tyne Hospitals Trust, Newcastle, United Kingdom.
Max J H WitjesDepartment of Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, The Netherlands.
Alex M WonDepartment of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mark E WongKatz Department of Oral and Maxillofacial Surgery, UTHealth Houston School of Dentistry, Houston, Texas.
Christopher M K L YaoDepartment of Otolaryngology Head and Neck Surgery, University Health Network, Princess Margaret Cancer Center/University Health Network, Toronto, Ontario, Canada.
Simon W YoungKatz Department of Oral and Maxillofacial Surgery, UTHealth Houston School of Dentistry, Houston, Texas.
Kamal Al-EryaniDepartment of Oral Medicine, Oral Pathology, and Oral Radiology, University of California, San Francisco, San Francisco, California.
Carly E A BarbonDepartment of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Doke J M BuurmanDepartment of Radiation Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Cranio-Maxillofacial Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
François J DielemanDepartment of Oral and Maxillofacial Surgery and Head and Neck Surgical Oncology, University Medical Center Utrecht Cancer Center, Utrecht, The Netherlands.
Theresa M HofstedeDepartment of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abdul Ahad KhanDepartment of Oral and Maxillofacial Surgery, Odense University Hospital, Odense, Denmark.
Adegbenga O OtunDepartment of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
John C RobinsonDepartment of Orofacial Sciences, University of California, San Francisco, San Francisco, California.
Lauren HumKatz Department of Oral and Maxillofacial Surgery, UTHealth Houston School of Dentistry, Houston, Texas.
Jorgen JohansenDepartment of Oncology, Odense University Hospital, Odense, Denmark.
Rajesh LallaDepartment of Oral and Maxillofacial Diagnostics Sciences, University of Connecticut, Farmington, Connecticut.
Alexander LinDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Vinod PatelDepartment of Oral Surgery, Guy's and St Thomas NHS Trust, London, United Kingdom.
Richard J ShawDepartment of Head & Neck Surgery, Molecular & Clinical Cancer Medicine, The University of Liverpool Cancer Research Centre/Aintree University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Mark S ChambersDepartment of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Daniel MaDepartment of Radiation Oncology, Mayo Clinic, Rochester, New York.
Mabi SinghDivision of Oral Medicine, Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, Massachusetts.
Noam YaromDepartment of Oral Medicine, Sheba Medical Center, Tel-Hashomer, Israel; Department of Dentistry, School of Dental Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Abdallah Sherif Radwan MohamedDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas.
Katherine A HutchesonDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Stephen Y LaiDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clifton David FullerDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Paul Calabresi Clinical Oncology AwardK12CA088084 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI David S. Hong, Scott Kopetz · 2000 to 2026
$14.0M
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic CancerP50CA221707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT, MAITRA, ANIRBAN · 2019 to 2023
$11.0M
Project 3: OPC-RADP01CA285249 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Clifton David Fuller, Katherine Arnold Hutcheson · 2024 to 2026
$9.4M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9M
Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)U01DE032168 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Clifton David Fuller, STEPHEN Y LAI · 2023 to 2026
$2.8M
Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)R25EB025787 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DAS, PRAJNAN, FULLER, CLIFTON DAVID · 2018 to 2022
$535k
Provider and Patient-generated Remote Oro-Dental Health Electronic Data Capture for Algorithmic Longitudinal Evaluation and Risk-Assessment (PROHEALER)K01DE030524 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2022 to 2024
$479k
Radiation-specific Automated Dental Dose Distributions via Machine-learning based Mapping for Accurate Predictions of (Peri)odontal Problems (RADMAP)R21DE031082 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2021 to 2022
$452k
BLRD VA IK2 BX004360NCI NIH HHS K12 CA088084NCI NIH HHS P01 CA285249NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA221707NIBIB NIH HHS R25 EB025787NIDCR NIH HHS K01 DE030524NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R21 DE031082NIDCR NIH HHS U01 DE032168
6 · The paper itself

Abstract

purposeOsteoradionecrosis of the jaw (ORNJ) is a severe iatrogenic disease characterized by bone death after radiation therapy to the head and neck. With >9 published definitions and at least 16 classification systems, the true incidence and severity of ORNJ are obscured by lack of a standard for disease definition and severity assessment, leading to inaccurate estimation of incidence, reporting ambiguity, and likely underdiagnosis worldwide. This study aimed to achieve consensus on an explicit definition and phenotype of ORNJ and related precursor states through data standardization to facilitate effective diagnosis, monitoring, and multidisciplinary management of ORNJ. METHODS AND MATERIALS: The Orodental Radiotherapy-Associated Late-Effects Consortium comprised 69 international experts, including representatives from medical, surgical, radiation oncology, and oral/dental disciplines. Using a web-based modified Delphi technique, panelists classified descriptive cases using existing classification systems, reviewed systems for feature extraction and specification, and iteratively classified cases based on clinical/imaging feature combinations.

resultsThe Consortium ORNJ definition was developed in alignment with Systematized Nomenclature of Medicine - Clinical Terms (SNOMED-CT) terminology and recent International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and the American Society of Clinical Oncology (ISOO-MASCC-ASCO) guideline recommendations. Case review using existing ORNJ classification systems showed high rates of inability to classify (up to 76%). Ten consensus statements and 9 minimum data elements (MDEs) were outlined for prospective collection and classification of precursor/ORNJ disease states.

conclusionsThis study provides an international, consensus-based definition and MDE foundation for standardized ORNJ reporting in cancer survivors treated with radiation therapy. Head and neck surgeons, radiation, surgical, medical oncologists, and dental specialists should adopt MDEs to enable scalable health information exchange and analytics. Work is underway to develop both a human- and machine-readable knowledge representation for ORNJ (ie, ontology) and multidisciplinary resources for dissemination to improve ORNJ reporting in academic and community practice settings.

Indexed as

Delphi TechniqueJaw DiseasesOsteoradionecrosisHead and Neck NeoplasmsHumansTerminology as Topic

Identifiers

PMID39826846
PMCPMC12303726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.